Amlodipine-d4
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Amlodipine-d4
Description :
Amlodipine-d4 is a deuterium labeled Amlodipine (HY-B0317) . Amlodipine, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine can be used for the research of high blood pressure and cancer[1][2][3].UNSPSC :
12352005Hazard Statement :
H301, H315, H318, H373, H410Target :
Calcium Channel; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
Membrane Transporter/Ion Channel; Neuronal Signaling; OthersApplications :
Cancer-programmed cell deathField of Research :
CancerPurity :
98.46Solubility :
DMSO : 31.25 mg/mL (ultrasonic; warming)Smiles :
CCOC(C1=C(COC([2H])([2H])C([2H])([2H])N)NC(C)=C(C(OC)=O)C1C2=C(C=CC=C2)Cl)=OMolecular Formula :
C20H21D4ClN2O5Molecular Weight :
412.90Precautions :
H301, H315, H318, H373, H410References & Citations :
[1]Kishen G. Bulsara, et al. Amlodipine.|[2]Haria M, et al. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease [published correction appears in Drugs 1995 Nov;50 (5) :896]. Drugs. 1995;50 (3) :560-586.|[3]Yoshida J, et, al. Antitumor effects of amlodipine, a Ca2+ channel blocker, on human epidermoid carcinoma A431 cells in vitro and in vivo. Eur J Pharmacol. 2004 May 25;492 (2-3) :103-12.|[4]Okuyama Y, et, al. The effects of anti-hypertensive drugs and the mechanism of hypertension in vascular smooth muscle cell-specific ATP2B1 knockout mice. Hypertens Res. 2018 Feb;41 (2) :80-87.|[5]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-246.Shipping Conditions :
Blue IceStorage Conditions :
-20°C, 3 years (Powder)Scientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedCAS Number :
[1185246-14-3]

